WIDE RANGE OF INTERMEDIATE PRODUCTS FOR THE PHARMACEUTICAL INDUSTRY - BACK TO EUROPE

Pharma

We offer more than just a product, we provide future-oriented solutions with the following intermediate products.

Bioselect^® (high-purity guanidine salts) for biotechnological, diagnostic and pharmaceutical applications.
Cyanamide as an anti-worm agent for human and veterinary medicine.
Dicyandiamide as a synthesis building block for active pharmaceutical ingredients (API's), e.g. for the production of metformin (medication against type II diabetes).
NITRALZ^® (nitriles) for the API production of various medicines for the treatment of e.g. hypertension, heart disease, HIV and cancer.
NIGU^® (Nitroguanidine) as an intermediate in the synthesis of pharmaceuticals and veterinary products
Thiourea as a raw material for the production of various human medicines, e.g. for the treatment of Parkinson's disease.
Creavitalis^® (Creatine Monohydrate) raw material for health applications for vitality and well-being by supporting energy metabolism.

Product
News and Stories

Innovation, sustainability, health & safety play a fundamental role.

We have more than 60 years of experience in the development and manufacture of advanced, high-quality specialty and intermediate products for pharmaceutical applications.

In cooperation with you, we develop tailor-made solutions, such as customized buffer solutions based on guanidine thiocyanate and guanidine hydrochloride. Thanks to our many years of experience and our wide range of technologies, we can offer you a comprehensive service.

Due to our deep market and customer understanding and our stable supply chain, we are able to offer reliable and consistently high quality "Made in Germany" products.

Labor Reagenzglas Pflanzen Pipette Nahaufnahme

Bioselect®

Toll manufacturing

Cyanamide

Dicyandiamide

Nitralz®

Thiourea

Creavitalis®

Pharma Flyer

PDF

Pharma Flyer

2 MB

Act now.

Act together.

The Alzchem Group forms a unique production network. Such an interconnected system conserves resources, saves energy, reduces emissions, transport costs and uses the synergies of an integrated infrastructure.

News and Stories

Alzchem, Corporate News

Alzchem Group AG significantly increases EBITDA in Q3 23

Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, successfully held its ground in the first nine months of 2023. Despite a slight decline in sales of 2.7% from EUR 409.0 million to EUR 397.9 million, all key earnings figures were increased.

ein Person zeigt mit dem Stift auf ein Mac-Book

Ad-Hoc, Alzchem

Alzchem Group AG raises EBITDA forecast

Alzchem Group AG is significantly raising its earnings forecast for the full year 2023 despite a slightly lower sales expectation. Group EBITDA is expected to grow to approximately EUR 80 million (original forecast: up to EUR 70 million). Group sales are expected to be at or slightly below the previous year’s level of EUR 542.2 million; this is slightly below the most recent forecast.

Alzchem, Animal Nutrition, Sustainability

Modern poultry farming with Creamino^®

A good start in the life of a growing broiler chicken is crucial for their later development. But especially the time around hatching is very demanding for the young broilers.

Alzchem, Event, Fine Chemicals

JEC World 2024

JEC World is the global trade fair for composites and will take place from March 5th to March 7th in Paris.

Alzchem, Event, Fine Chemicals

Chemspec Europe 2024

The 37th international trade fair for fine and specialty chemicals, Chemspec Europe, will take place this year from June 19th to June 20th in Düsseldorf.